Case Report
Fulminant Hepatic Failure Secondary to Primary Hepatic Angiosarcoma
Table 1
Laboratory tests two months prior to presentation, at presentation, and at the time of patient’s death.
| Laboratory tests | Normal range | 2 months prior to presentation | At presentation | Time of death |
| Liver function tests | | | | | Total bilirubin | 0.3–1.2 mg/dL | 0.9 | 9.8 | 27 | Direct bilirubin | 0–0.3 mg/dL | 0.2 | 6.3 | 18.5 | Alkaline phosphatase | 36–92 U/L | 81 | 383 | 1120 | Gamma-glutamyl transferase | 0–30 U/L | 58 | 701 | 1200 | Aspartate aminotransferase | 0–35 U/L | 25 | 104 | 5522 | Alanine aminotransferase | 0–35 U/L | 21 | 206 | 2313 | Prothrombin time | 11–13 sec | 14.1 | 14.8 | 43.2 | Partial thromboplastin time | 25–35 sec | 27.5 | 34.6 | 69.9 | International normalized ratio | | 1.10 | 1.16 | 4.97 | Lactate dehydrogenase (LDH) | 60–100 U/L | 190 | 451 | 20000 | Peripheral blood cell count | | | | | Hemoglobin, g/L | 12.6–16.8 | 14.4 | 14.1 | 5.5 | White blood cell count, /L | 3.7–10.5 × 109 | 5.4 | 6.5 | 26 | Platelet count, /L | 167–400 × 109 | 144 | 143 | 22 | Blood chemistry | | | | | Sodium, mmol/L | 135–144 | 145 | 139 | 123 | Potassium, mmol/L | 3.5–5 | 4.6 | 5.1 | 5.4 | Chloride, mmol/L | 100–110 | 110 | 104 | 95 | Bicarbonate, mmol/L | 23–31 | 24 | 24 | 10 | Blood urea nitrogen, mmol/L (mg/dL) | 2.85–7.14 (7.98–20) | 15 | 20 | 80 | Creatinine, mmol/L (mg/dL) | 53.0–123.7 (0.6–1.4) | 0.8 | 1.2 | 6.3 |
|
|